Biology:HSP90B1

From HandWiki
Short description: Protein-coding gene in the species Homo sapiens


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

Heat shock protein 90kDa beta member 1 (HSP90B1), known also as endoplasmin, gp96, grp94, or ERp99, is a chaperone protein that in humans is encoded by the HSP90B1 gene.[1][2]

HSP90B1 is an HSP90 paralogue that is found in the endoplasmic reticulum. It plays critical roles in folding proteins in the secretory pathway such as Toll-like receptors and integrins.[3][4] It has been implicated as an essential immune chaperone to regulate both innate and adaptive immunity.[5] Tumor-derived HSP90B1 (vitespen) has entered clinical trials for cancer immunotherapy.[6][7][8][9]

grp94 has been shown to be a target for treatment of a plethora of diseases such as glaucoma, multiple myeloma, and metastatic cancer. grp94 includes 5 distinct amino acids in its primary sequence which creates 2 unique sub-pockets, S1 and S2. These sub-pockets have been utilized in current research in order to inhibit the chaperone since its client proteins seem to be up-regulated in cancer cells.[10]

References

  1. "Human homologue of murine tumor rejection antigen gp96: 5'-regulatory and coding regions and relationship to stress-induced proteins". Proceedings of the National Academy of Sciences of the United States of America 87 (15): 5658–62. August 1990. doi:10.1073/pnas.87.15.5658. PMID 2377606. Bibcode1990PNAS...87.5658M. 
  2. "The HSP90 family of genes in the human genome: insights into their divergence and evolution". Genomics 86 (6): 627–37. December 2005. doi:10.1016/j.ygeno.2005.08.012. PMID 16269234. 
  3. "Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability". Nature Cell Biology 3 (10): 891–6. October 2001. doi:10.1038/ncb1001-891. PMID 11584270. 
  4. "Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages". Immunity 26 (2): 215–26. February 2007. doi:10.1016/j.immuni.2006.12.005. PMID 17275357. ,
  5. "gp96--the immune system's Swiss army knife". Nature Immunology 1 (2): 100–1. August 2000. doi:10.1038/77770. PMID 11248798. 
  6. "Vitespen: a preclinical and clinical review". Future Oncology 5 (6): 763–74. August 2009. doi:10.2217/fon.09.46. PMID 19663726. 
  7. "HSPPC-96 vaccine in metastatic melanoma patients: from the state of the art to a possible future". Expert Review of Vaccines 8 (11): 1513–26. November 2009. doi:10.1586/erv.09.108. PMID 19863242. 
  8. "NCT00293423". ClinicalTrials.gov, United States National Institutes of Health. http://clinicaltrials.gov/ct2/show/NCT00293423. "GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma" 
  9. "Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial". Neuro-Oncology 16 (2): 274–9. January 2014. doi:10.1093/neuonc/not203. PMID 24335700. 
  10. "Resorcinol-Based Grp94-Selective Inhibitors" (in EN). ACS Medicinal Chemistry Letters 8 (10): 1013–1018. October 2017. doi:10.1021/acsmedchemlett.7b00193. PMID 29057043. 

Further reading